Altered levels of pro-inflammatory interleukins IL-6 and IL-1β and tumor necrosis factor (TNF) have been described in ALS cases (Hu et al., 2017; Tortelli et al., 2020). This evidence concerns the gene TNF and amyotrophic lateral sclerosis.